Treatment outcome of Philadelphia chromosome negative myeloproliferative neoplasms: experience of a single developing country ’s hematology-oncology centre

Conclusion: Clinical and laboratory improvements were presented in MPNs patients. Regular follow up of patients are essential to ensure prescribed treatment in addition to the continual and long-lasting response to therapy and to prevent thrombosis.Keywords: Cytoreductive treatment, MPNs, JAK2 mutation.
Source: African Health Sciences - Category: African Health Source Type: research